Back
ProShares UltraShort Nasdaq Biotech Vs. FirstCash Holdings Industry Stock Comparison
Sell
22
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
18.08
Seasonality Move:
-12.5%
Buy
58
FCFS
FirstCash Holdings
Last Price:
119.05
Seasonality Move:
2.79%
Sell
22
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $18.10. The Score for BIS is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
FirstCash Holdings (FCFS)
is a Buy
Is FirstCash Holdings a Buy, Sell or Hold?
- The current FirstCash Holdings [FCFS] share price is $116.51. The Score for FCFS is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- FCFS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $18.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIS is experiencing slight buying pressure.
FCFS Stock Price Chart
What is FirstCash Holdings's stock price today?
-
The FirstCash Holdings share price today is $116.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCFS is experiencing slight selling pressure.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 39.62 | Sell |
| Chaikin Money Flow: | 278 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.59 - 20.37) | Sell |
| Bollinger Bands (100): | (17.25 - 19.39) | Sell |
FCFS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.43 | Sell |
| Relative Strength Index (14 RSI): | 39.27 | Sell |
| Chaikin Money Flow: | -60658 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.48 - 131.08) | Sell |
| Bollinger Bands (100): | (110.61 - 124.15) | Sell |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.26 | Sell |
| 20-day SMA: | 19.66 | Sell |
| 50-day SMA: | 18.54 | Sell |
| 200-day SMA: | 20.37 | Sell |
| 8-day EMA: | 18.97 | Sell |
| 20-day EMA: | 19.27 | Sell |
| 50-day EMA: | 18.95 | Sell |
| 200-day EMA: | 19.75 | Sell |
FCFS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 115.13 | Buy |
| 20-day SMA: | 124.24 | Sell |
| 50-day SMA: | 121.6 | Sell |
| 200-day SMA: | 109.19 | Buy |
| 8-day EMA: | 117.49 | Sell |
| 20-day EMA: | 121.04 | Sell |
| 50-day EMA: | 121.12 | Sell |
| 200-day EMA: | 111.4 | Buy |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
FirstCash Holdings Earnings Growth & FCFS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.05 per share, and an increase next year of $1.23 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
FirstCash Holdings Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||